Clinical Trials
2 trialsNCT05332574 2022-08-05
A Safety, Tolerability, PK and Preliminary Activity Study of GB263T in Advanced NSCLC and Other Solid Tumor
Genor Biopharma Co., Ltd.
Phase 1/2 Unknown
NCT04413227 2020-06-02
A Phase Ib Study With Pegylated Recombinant Human Endostatin in Advanced / Metastatic NSCLC or Other Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1 Unknown